Genflow Biosciences Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.11	0.28	0.68	2.36	0.22
Cash & Short-Term Investments	0.11	0.28	0.68	2.36	0.22
Cash Growth	-59.88%	-59.26%	-70.97%	951.87%	-
Accounts Receivable	0.34	-	-	-	-
Other Receivables	-	0.04	0.34	0.13	0.02
Receivables	0.34	0.04	0.34	0.13	0.02
Prepaid Expenses	-	0.07	0.04	0.13	0.03
Total Current Assets	0.45	0.38	1.07	2.62	0.28
Property, Plant & Equipment	0	0	0	0	-
Total Assets	0.45	0.39	1.07	2.62	0.28
Accounts Payable	1	0.37	0.48	0.08	0.04
Accrued Expenses	-	0.07	0.06	0.16	0.17
Current Unearned Revenue	-	0.33	-	-	-
Other Current Liabilities	-	0.02	0.03	0.01	0.01
Total Current Liabilities	1	0.79	0.57	0.25	0.22
Total Liabilities	1	0.79	0.57	0.25	0.22
Common Stock	0.15	0.1	0.09	0.09	0.07
Additional Paid-In Capital	6.1	4.83	4.19	4.19	0.63
Retained Earnings	-7.01	-5.59	-4	-2.14	-0.81
Comprehensive Income & Other	0.21	0.25	0.22	0.23	0.16
Shareholders' Equity	-0.55	-0.4	0.5	2.37	0.06
Total Liabilities & Equity	0.45	0.39	1.07	2.62	0.28
Net Cash (Debt)	0.11	0.28	0.68	2.36	0.22
Net Cash Growth	-59.88%	-59.26%	-70.97%	951.87%	-
Net Cash Per Share	0.00	0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	469.67	349.71	292.51	292.51	292.51
Total Common Shares Outstanding	469.67	349.71	292.51	292.51	244.57
Working Capital	-0.55	-0.41	0.5	2.36	0.06
Book Value Per Share	-0.00	-0.00	0.00	0.01	0.00
Tangible Book Value	-0.55	-0.4	0.5	2.37	0.06
Tangible Book Value Per Share	-0.00	-0.00	0.00	0.01	0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.